InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

- Current share price for NOX : $0.080

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Change of Director's Interest Notice - FB 4 May 2023 5:00PM $0.048 $0.080 risen by 66.67%
$25 March 2023 Quarterly Activities Report and Appendix 4C 24 Apr 2023 8:38AM $0.069 $0.080 risen by 15.94%
$25 Noxopharm to Prioritise Cutting-Edge Chroma & Sofra Programs 6 Apr 2023 8:08AM $0.110 $0.080 fallen by 27.27%
$25 Noxopharm Announces Novel mRNA Vaccine Enhancer 28 Mar 2023 8:17AM $0.095 $0.080 fallen by 15.79%
$25 Appendix 4D and Half Year 2023 Financial Report 24 Feb 2023 1:24PM $0.105 $0.080 fallen by 23.81%
$25 Noxopharm to Present Sofra Study at LUPUS 2023 Conference 22 Feb 2023 8:07AM $0.110 $0.080 fallen by 27.27%
$25 December 2022 Quarterly Activities Report and Appendix 4C 27 Jan 2023 8:32AM $0.140 $0.080 fallen by 42.86%
$25 DARRT-2 Trial Efficacy Phase to Commence 17 Jan 2023 8:27AM $0.135 $0.080 fallen by 40.74%
$25 NOX Pipeline Boosted by $1.5M Grant to Hudson Institute 16 Dec 2022 8:20AM $0.145 $0.080 fallen by 44.83%
$25 Change of Director's Interest Notice - FB 15 Dec 2022 4:24PM $0.145 $0.080 fallen by 44.83%
$25 Notification of cessation of securities - NOX 15 Dec 2022 4:21PM $0.145 $0.080 fallen by 44.83%
$25 Federal Innovation Connections Grant Awarded 6 Dec 2022 8:52AM $0.165 $0.080 fallen by 51.52%
$25 IONIC Trial Progresses as Veyonda Passes Safety Milestone 2 Dec 2022 8:18AM $0.160 $0.080 fallen by 50%
$25 Notification of cessation of securities - NOX 21 Nov 2022 5:01PM $0.160 $0.080 fallen by 50%
$25 Constitution 17 Nov 2022 4:36PM $0.160 $0.080 fallen by 50%
$25 Results of Meeting 17 Nov 2022 4:32PM $0.160 $0.080 fallen by 50%
$25 Noxopharm 2022 AGM Corporate Presentation 17 Nov 2022 8:55AM $0.145 $0.080 fallen by 44.83%
$25 Noxopharm AGM 2022 Chair's Address 17 Nov 2022 8:53AM $0.145 $0.080 fallen by 44.83%
$25 CEP-2 Safety Milestone Shows Veyonda Progress 16 Nov 2022 8:32AM $0.145 $0.080 fallen by 44.83%
$25 Noxopharm Enhances Cash Position via R&D Rebate 10 Nov 2022 9:49AM $0.145 $0.080 fallen by 44.83%
$25 Change in substantial holding 25 Oct 2022 8:51AM $0.190 $0.080 fallen by 57.89%
$25 September 2022 Quarterly Activities Report and Appendix 4C 21 Oct 2022 8:20AM $0.180 $0.080 fallen by 55.56%
$25 2022 AGM Notice of Meeting and Proxy 18 Oct 2022 9:04AM $0.190 $0.080 fallen by 57.89%
$25 2022 AGM Letter to Shareholders and Proxy 18 Oct 2022 8:51AM $0.190 $0.080 fallen by 57.89%
$25 Unlisted Options Expiring on 21 November 2022 7 Oct 2022 9:25AM $0.180 $0.080 fallen by 55.56%

151 - 175 of 794 results

Page 7 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.